Preclinical evaluation of 68Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2021)Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification Adv Cancer Res 149 1-61

[3] Siegel RL(2013)Positron emission tomography-computed tomography in liver imaging Semin Ultrasound CT MR 34 66-80

[4] Laversanne M(2016)Diagnostic value of combining Eur J Nucl Med Mol Imaging 43 852-859

[5] Soerjomataram I(2017)C-choline and Q J Nucl Med Mol Imaging 61 292-300

[6] Jemal A(2017)F-FDG PET/CT in hepatocellular carcinoma Eur J Nucl Med Mol Imaging 44 1732-1741

[7] Bray F(2015)Imaging of primary liver tumors with positron-emission tomography Eur J Nucl Med Mol Imaging 42 1399-1407

[8] Chidambaranathan-Reghupaty S(2019)The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab Expert Rev Med Devices 16 341-350

[9] Fisher PB(2021)Diagnostic accuracy of (1)(1)C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma Eur J Nucl Med Mol Imaging 48 1593-1603

[10] Sarkar D(2022)Recent advances in PET probes for hepatocellular carcinoma characterization Eur J Nucl Med Mol Imaging 49 4000-4013

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2021)Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification Adv Cancer Res 149 1-61

[3] Siegel RL(2013)Positron emission tomography-computed tomography in liver imaging Semin Ultrasound CT MR 34 66-80

[4] Laversanne M(2016)Diagnostic value of combining Eur J Nucl Med Mol Imaging 43 852-859

[5] Soerjomataram I(2017)C-choline and Q J Nucl Med Mol Imaging 61 292-300

[6] Jemal A(2017)F-FDG PET/CT in hepatocellular carcinoma Eur J Nucl Med Mol Imaging 44 1732-1741

[7] Bray F(2015)Imaging of primary liver tumors with positron-emission tomography Eur J Nucl Med Mol Imaging 42 1399-1407

[8] Chidambaranathan-Reghupaty S(2019)The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab Expert Rev Med Devices 16 341-350

[9] Fisher PB(2021)Diagnostic accuracy of (1)(1)C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma Eur J Nucl Med Mol Imaging 48 1593-1603

[10] Sarkar D(2022)Recent advances in PET probes for hepatocellular carcinoma characterization Eur J Nucl Med Mol Imaging 49 4000-4013